IN2014MN01420A - - Google Patents
Info
- Publication number
- IN2014MN01420A IN2014MN01420A IN1420MUN2014A IN2014MN01420A IN 2014MN01420 A IN2014MN01420 A IN 2014MN01420A IN 1420MUN2014 A IN1420MUN2014 A IN 1420MUN2014A IN 2014MN01420 A IN2014MN01420 A IN 2014MN01420A
- Authority
- IN
- India
- Prior art keywords
- cells
- subpopulation
- pbmcs
- optionally
- treatment
- Prior art date
Links
- 210000004027 cell Anatomy 0.000 abstract 4
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 abstract 2
- 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 abstract 1
- 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 abstract 1
- 101000917858 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-A Proteins 0.000 abstract 1
- 101000917839 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-B Proteins 0.000 abstract 1
- 101000581981 Homo sapiens Neural cell adhesion molecule 1 Proteins 0.000 abstract 1
- 102100029185 Low affinity immunoglobulin gamma Fc region receptor III-B Human genes 0.000 abstract 1
- 102100027347 Neural cell adhesion molecule 1 Human genes 0.000 abstract 1
- 208000027418 Wounds and injury Diseases 0.000 abstract 1
- 230000006378 damage Effects 0.000 abstract 1
- 208000014674 injury Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/15—Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4614—Monocytes; Macrophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
- A61K39/4622—Antigen presenting cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/46432—Nervous system antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0645—Macrophages, e.g. Kuepfer cells in the liver; Monocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
- A61K2239/38—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the dose, timing or administration schedule
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Developmental Biology & Embryology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161570593P | 2011-12-14 | 2011-12-14 | |
| PCT/IL2012/050522 WO2013088441A1 (en) | 2011-12-14 | 2012-12-13 | Human monocyte sub-population for treatment of central nervous system injury |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014MN01420A true IN2014MN01420A (es) | 2015-04-03 |
Family
ID=48611950
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1420MUN2014 IN2014MN01420A (es) | 2011-12-14 | 2012-12-13 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US9314483B2 (es) |
| EP (1) | EP2790712B1 (es) |
| JP (1) | JP6148679B2 (es) |
| KR (1) | KR20140107439A (es) |
| CN (1) | CN104159590A (es) |
| AU (2) | AU2012354057B2 (es) |
| BR (1) | BR112014014560A8 (es) |
| DK (1) | DK2790712T3 (es) |
| ES (1) | ES2604356T3 (es) |
| HU (1) | HUE032096T2 (es) |
| IN (1) | IN2014MN01420A (es) |
| MX (1) | MX358589B (es) |
| PL (1) | PL2790712T3 (es) |
| PT (1) | PT2790712T (es) |
| WO (1) | WO2013088441A1 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10240125B2 (en) | 2013-03-14 | 2019-03-26 | Immusoft Corporation | Methods for in vitro memory B cell differentiation and transduction with VSV-G pseudotyped viral vectors |
| EP2999479B1 (en) * | 2013-05-22 | 2021-01-06 | Yeda Research and Development Co., Ltd. | Human monocyte sub-population for treatment of eye diseases and disorders |
| WO2016100932A1 (en) * | 2014-12-19 | 2016-06-23 | Immusoft Corporation | B cells for in vivo delivery of therapeutic agents |
| WO2017096246A1 (en) * | 2015-12-03 | 2017-06-08 | Temple University-Of The Commonwealth System Of Higher Education | Modulation of nad+ and nad+ metabolic pathways for treatment of disease |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5800812A (en) | 1995-09-15 | 1998-09-01 | Yeda Research And Development Co. Ltd. | Methods of use of mononuclear phagocytes to promote axonal regeneration |
| US6194204B1 (en) * | 1996-08-02 | 2001-02-27 | Center For Blood Research, Inc. | Enrichment of dendritic cells from blood |
| US6267995B1 (en) | 1999-03-03 | 2001-07-31 | Pure World Botanicals, Inc. | Extract of Lepidium meyenii roots for pharmaceutical applications |
| IL162094A0 (en) | 2001-11-21 | 2005-11-20 | Yeda Res & Dev | Process for the manufacture of human mononuclear phagocytic leukocytes |
| CN102036671A (zh) * | 2008-03-28 | 2011-04-27 | 永生细胞生技股份有限公司 | 使用脐带血细胞治疗脑损伤 |
| EP2999479B1 (en) * | 2013-05-22 | 2021-01-06 | Yeda Research and Development Co., Ltd. | Human monocyte sub-population for treatment of eye diseases and disorders |
-
2012
- 2012-12-13 MX MX2014007188A patent/MX358589B/es active IP Right Grant
- 2012-12-13 CN CN201280069645.XA patent/CN104159590A/zh active Pending
- 2012-12-13 PL PL12858248T patent/PL2790712T3/pl unknown
- 2012-12-13 IN IN1420MUN2014 patent/IN2014MN01420A/en unknown
- 2012-12-13 JP JP2014546730A patent/JP6148679B2/ja active Active
- 2012-12-13 WO PCT/IL2012/050522 patent/WO2013088441A1/en active Application Filing
- 2012-12-13 BR BR112014014560A patent/BR112014014560A8/pt not_active IP Right Cessation
- 2012-12-13 DK DK12858248.3T patent/DK2790712T3/en active
- 2012-12-13 ES ES12858248.3T patent/ES2604356T3/es active Active
- 2012-12-13 HU HUE12858248A patent/HUE032096T2/en unknown
- 2012-12-13 PT PT128582483T patent/PT2790712T/pt unknown
- 2012-12-13 EP EP12858248.3A patent/EP2790712B1/en active Active
- 2012-12-13 AU AU2012354057A patent/AU2012354057B2/en active Active
- 2012-12-13 KR KR1020147019424A patent/KR20140107439A/ko active IP Right Grant
-
2014
- 2014-06-12 US US14/303,212 patent/US9314483B2/en not_active Expired - Fee Related
-
2017
- 2017-10-31 AU AU2017254830A patent/AU2017254830A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| MX2014007188A (es) | 2015-09-22 |
| US20140363411A1 (en) | 2014-12-11 |
| KR20140107439A (ko) | 2014-09-04 |
| PL2790712T3 (pl) | 2017-04-28 |
| BR112014014560A2 (pt) | 2017-06-13 |
| AU2017254830A1 (en) | 2017-11-16 |
| CN104159590A (zh) | 2014-11-19 |
| PT2790712T (pt) | 2016-12-02 |
| US9314483B2 (en) | 2016-04-19 |
| WO2013088441A1 (en) | 2013-06-20 |
| EP2790712B1 (en) | 2016-08-31 |
| HUE032096T2 (en) | 2017-09-28 |
| EP2790712A4 (en) | 2015-06-24 |
| AU2012354057A1 (en) | 2014-07-31 |
| AU2012354057B2 (en) | 2017-08-03 |
| ES2604356T3 (es) | 2017-03-06 |
| JP2015501835A (ja) | 2015-01-19 |
| MX358589B (es) | 2018-08-27 |
| BR112014014560A8 (pt) | 2017-07-04 |
| EP2790712A1 (en) | 2014-10-22 |
| JP6148679B2 (ja) | 2017-06-14 |
| DK2790712T3 (en) | 2016-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20180959T1 (hr) | Ljudska protutijela za pcsk9 za uporabu u postupcima liječenja određenih skupina subjekata | |
| MX2019014009A (es) | Metodos mejorados para la elaboracion de terapias celulares adoptivas. | |
| MY185016A (en) | Progenitor cells of mesodermal lineage | |
| EP2710139A4 (en) | ANALYSIS AND SORTING OF MOTILATED CELLS | |
| TN2013000468A1 (en) | Use of anti-cd19 maytansinoid immunoconjugate antibody for the treatment of b-cell malignancies symptoms | |
| MA34818B1 (fr) | Anticorps anti-pcsk9 et procédés d'utilisation | |
| IN2015KN00666A (es) | ||
| UA104663C2 (en) | Antibody binding to cd127 | |
| EA201390387A1 (ru) | Средства и способы лечения диффузной в-крупноклеточной лимфомы (dlbcl) | |
| MX2009009283A (es) | Anticuerpos anti-interleuquina -23r de ingenieria. | |
| IN2014MN01420A (es) | ||
| MY170934A (en) | Treatment of pain associated with dislocation of basal endometrium | |
| MX2014004696A (es) | Disposicion de articulos absorbentes desechables. | |
| IL276077A (en) | The in vitro fertilization method with delayed embryo transfer and the use of mononuclear cells from peripheral blood | |
| GB201109238D0 (en) | Antibodies | |
| EP2736473A4 (en) | ABSORBENT ARTICLE WITH A BELT WITH SPECIFIC KINETIC FRESH COEFFICIENT AND SUCTION CUSHIONS WITH SPECIFIC KINETIC FRESH COEFFICIENT | |
| EP2593115A4 (en) | TREATMENT OF T-CELL-MEDIATED IMMUNE TROUBLESHOOTING | |
| MX2013015146A (es) | Biomarcador predictivo de supervivencia en el tratamiento de carcinoma de celulas renales. | |
| HK1198471A1 (en) | Thermally-conductive, metal-based bandages to aid in medical healing and methods of use | |
| GB2510524A (en) | Pulmonary hypertension | |
| IN2015DN00172A (es) | ||
| MX2013012083A (es) | Biomarcadores para el tratamiento de mieloma multiple. | |
| UA48629U (ru) | Способ обогащения магнетически очищенных cd34 позитивных стволовых гемопоэтических клеток | |
| UA70181U (ru) | Способ иммунологической оценки эффективности интерферонотерапии у больных с меланомой кожи | |
| GEU20131763Y (en) | Phototherapeutic device "aisi 2" |